Somavert (pegvisomant) — United Healthcare
Acromegaly
Initial criteria
- Diagnosis of acromegaly
- AND
- One of the following:
- Inadequate response to one of the following: surgery OR radiation therapy
- OR
- Not a candidate for either surgery OR radiation therapy
Reauthorization criteria
- Documentation of positive clinical response to Somavert therapy
Approval duration
12 months